Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs

Journal of the American Veterinary Medical Association

Volumn 228, Issue 2, 2006, Pages 210-215

  Fulcher, Ryan P ^a,b   Ludwig, Lori L ^a,c   Bergman, Philip J ^a   Newman, Shelley J ^a,d   Simpson, Amelia M ^a,e   Patnaik, Amiya K ^a  

^a ANIMAL MEDICAL CENTER   (United States)

^b Garden State Veterinary Specialists   (United States)

^c Veterinary Surgical Care LLC   (United States)

^d UNIVERSITY OF TENNESSEE   (United States)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISONE; VINBLASTINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; FEMALE; MALE; MASTOCYTOMA; NONHUMAN; PROGNOSIS; SKIN TUMOR; SURVIVAL; TUMOR RECURRENCE;

ANIMALS; DISEASE-FREE SURVIVAL; DOG DISEASES; DOGS; FEMALE; MALE; MAST-CELL SARCOMA; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS;

EID: 30744466175     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.228.2.210     Document Type: Article

References (29)

1. Thamm DH, Vail DM. Mast cell tumors. In: Withrow SJ, MacEwan EG, eels. Small animal clinical oncology. 3rd ed. Philadelphia: WB Saunders Co, 2001;261-282.
2. Macy DW. Canine and feline mast cell tumors: biologic behavior, diagnosis, and therapy. Semin Vet Med Surg (Small Anim)
3. Rogers KS. Mast cell tumors: dilemmas of diagnosis and treatment. Vet Clin North Am Small Anim Pract 1996;26:87-102.
4. Simoes JPC, Shoning P, Butine M. Prognosis of canine mast cell tumors: a comparison of three methods. Vet Pathol 1994;31:637-647.
5. Strefezzi Rde F, Xavier JG, Catao-Dias JL. Morphometry of canine cutaneous mast cell tumors. Vet Pathol 2003;40:268-275.
6. Seguin B, Leibman NF, Bregazzi VS, et al. Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999). J Am Vet Med Assoc 2001;218:1120-1123.
7. Turrel JM, Kitchell BE, Miller LM, et al. Prognostic factors for radiation treatment of mast cell tumor in 85 dogs. J Am Vet Med Assoc 1988;193:936-940.
8. Bostock DE. The prognosis following surgical removal of mastocytomas in dogs. J Small Anim Pract 1973;14:27-40.
9. O'Keefe DA. Canine mast cell tumors. Vet Clin North Am Small Anim Pract 1990;20:1105-1115.
10. Hottendorf GH, Nielsen SW. Pathologic report of 29 necropsies on dogs with mastocytoma. Vet Pathol 1968;5:102-121.
11. Michels GM, Knapp DW, DeNicola DB, et al. Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases. J Am Anim Hosp Assoc 2002;38:458-466.
12. Jaffe MH, Hosgood G, Taylor HW, et al. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors. Vet Pathol 2000;37:40-46.
13. Geiger TL, Theon AP, Werner JA, et al. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990-2001). J Vet Intern Med 2003;17:687-692.
14. Ginn PE, Fox LE, Brower JC, et al. Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors. Vet Pathol 2000;37:33-39.
15. Ishiguro T, Kadosawa T, Takagi S, et al. Relationship of disease progression and plasma histamine concentrations in 11 dogs with mast cell tumors. J Vet Intern Med 2003;17:194-198.
16. O'Keefe DA, Couto CG, Burke-Schwartz C, et al. Systemic mastocytosis in 16 dogs. J Vet Intern Med 1987;1:75-80.
17. Patnaik AK, Ehler WJ, MacEwan EG. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol 1984;21:469-474.
18. Abadie JJ, Amardeilh MA, Delverdier ME. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs. J Am Vet Med Assoc 1999;215: 1629-1934.
19. McCaw DL, Miller MA, Bergman PJ, et al. Vincristine therapy for mast cell tumors in dogs. J Vet Intern Med 1997;11:375-378.
20. Simpson AM, Ludwig LL, Newman SJ, et al. Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs. J Am Vet Med Assoc 2004;224:236-240.
21. Weisse C, Shofer FS, Sorenmo K. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following surgical excision. J Am Anim Hosp Assoc 2002;38:71-73.
22. Cahalane AK, Payne S, Barber LG, et al. Prognostic factors for survival of dogs with inguinal and perineal mast cell tumors treated surgically with or without adjunctive treatment: 68 cases (1994-2002). J Am Vet Med Assoc 2004;224:401-408.
23. Murphy S, Sparkes AH, Smith KC, et al. Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection. Vet Rec 2004;154: 743-746.
24. Powers BE. The pathology of neoplasia. In: Withrow SJ, MacEwan EG, eds. Small animal clinical oncology. 2nd ed. Philadelphia: WB Saunders Co, 1996;4-15.
25. Leibman NF, Lana SE, Hansen RA, et al. Identification of matrix metalloproteinases in canine cutaneous mast cell tumors. J Vet Intern Med 2000;14:583-586.
26. Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995;332:429-435.
27. Gamblin RM, Sagartz JE, Couto CG. Overexpression of p53 tumor suppressor protein in spontaneously arising neoplasms of dogs. Am J Vet Res 1997;58:857-863.
28. Kravis LD, Vail DM, Kisseberth WC, et al. Frequency of argyrophilic nucleolar organizer regions in fine-needle aspirates and biopsy specimens from mast cell tumors in dogs. J Am Vet Med Assoc 1996;209:1418-1420.
29. Zavodovskaya R, Chien MB, London CA. Use of kit internal tandem duplications to establish mast cell tumor clonality in 2 dogs. J Vet Intern Med 2004;18:915-917.